Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Insulin Resistance and Motivation in Mood Disorders

NCT03915613 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03915613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03915613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Insulin Resistance and Motivation in Mood Disorders
Lead sponsor
University Health Network, Toronto
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 6, 2021
Completion date
October 5, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, bipolar disorder, intranasal insulin, major depressive disorder